ZM Szczepiorkowski, N Bandarenko, HC Kim, … - Journal of Clinical Apheresis, 2007 - aferesi.it The American Society for Apheresis (ASFA) Apheresis Applications Committee is
charged with a review and categorization of indications for therapeutic
apheresis. This elaborate process had been undertaken every 7 years ... Cited by 69 - Related articles - View as HTML - BL Direct - All 3 versions
AK Stewart, PL Bergsagel, PR Greipp, A … - Leukemia, 2007 - nature.com Clinical outcomes for multiple myeloma (MM) are highly heterogeneous and it is
now clear that pivotal genetic events are the primary harbingers of such
variation. These findings have broad implications for counseling, choice of ... Cited by 47 - Related articles - BL Direct - All 4 versions
- ►asnjournals.org CA Hutchison, P Cockwell, S Reid, K Chandler … - Journal of the American Society of Nephrology, 2007 - Am Soc Nephrol Of patients with newly diagnosed multiple myeloma, approximately 10% have
dialysis-dependent acute renal failure, with cast nephropathy, caused by
monoclonal free light chains (FLC). Of these, 80 to 90% require long-term ... Cited by 41 - Related articles - BL Direct - All 6 versions
JA Katzel, P Hari, DH Vesole - CA: A Cancer Journal for Clinicians, 2007 - Am Cancer Soc Multiple myeloma (MM) is an incurable clonal B-cell malignancy with terminally
differentiated plasma cells. It afflicts approximately 55,000 people in the
United States. Over the past 5 years, significant progress has been made in ... Cited by 28 - Related articles - BL Direct - All 4 versions
- ►haematologica.it H Ludwig, J Drach, H Graf, A Lang, JG Meran - Haematologica, 2007 - haematologica.it Paraprotein induced renal failure is a frequent complication of multiple myeloma
and is associated with poor survival. Previously, reversal of renal function has
been hampered by the lack of fast acting and highly effective myeloma ... Cited by 26 - Related articles - BL Direct - All 13 versions
- ►haematologica-thj.org E Kastritis, A Anagnostopoulos, M Roussou, … - Haematologica, 2007 - haematologica-thj.org The impact of high dose dexamethasone containing regimens with or without the
novel agents thalidomide and bortezomib on the reversal of renal failure (RF)
was evaluated in 41 consecutive newly diagnosed patients with multiple ... Cited by 20 - Related articles - BL Direct - All 12 versions
K El-Ghariani, DJ Unsworth - Clinical medicine, 2006 - cat.inist.fr Therapeutic apheresis-: plasmapheresis. Khaled EL-GHARIANI, David J UNSWORTH Clinical
medicine 6:44, 343-347, Royal College of Physicians, 2006. ... Cited by 19 - Related articles - BL Direct - All 3 versions
M Darmon, M Ciroldi, G Thiery, B Schlemmer, … - Crit Care, 2006 - biomedcentral.com Acute renal failure (ARF) in cancer patients is a dreadful complication that
causes substantial morbidity and mortality. Moreover, ARF may preclude optimal
cancer treatment by requiring a decrease in chemotherapy dosage or by ... Cited by 14 - Related articles - View as HTML - All 7 versions
MA Gertz - Leukemia & Lymphoma, 2007 - informahealthcare.com The management of renal failure in patients with newly-diagnosed multiple
myeloma remains an ongoing challenge for practicing clinicians. In this issue of
Leukemia and Lymphoma, the Greek Myeloma Study Group reports an incidence ... Cited by 14 - Related articles - BL Direct - All 7 versions
